“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Recurrent and metastatic non-nasopharyngeal head and neck cancer: state of the art of systemic treatment

€3.03

SKU: product-article-11099 Category: General

Description

Description

Recurrent and metastatic non-nasopharyngeal head and neck cancer: state of the art of systemic treatment

Top

Article: Recurrent and metastatic non-nasopharyngeal head and neck cancer: state of the art of systemic treatment

Description

Related products

Article: INTRODUCTION

Article: Highlights in melanoma

Article: Highlights in digestive oncology

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer